Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:46:00.684Z.
Calculation as of: 2026-10-06T14:46:00.684Z.
Quote observation: 2026-10-06T14:44:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b7114033928f702054061c44125c31231f02474951b0017c983a2cfe9aac3c1c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$122.96M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$126.43M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$121.22M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$119.72M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$129.68M
Operating Cash Flow Yield
21.77%
TTM Avg
12.96%
3Y Avg
8.76%
5Y Avg
8.76%
Market Cap
$117.21M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$117.11M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.99M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $123.66M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $122.96M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $126.43M | N/A | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $121.22M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $119.72M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $129.68M | 21.77% | 12.96% | 8.76% | 8.76% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $117.21M | N/A | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $117.11M | N/A | N/A | N/A | N/A |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.99M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $131.08M | N/A | 1.70% | 1.70% | 1.70% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
